Locate Bio
Locate is based in MediCity and has developed a family of unique, thermally-activated, injectable scaffolds that solidify within the body and can be used to support tissue growth before degrading away.

Profile
The TAOSTM (Targeted, Orchestrated Signalling) technology is a world first in tissue repair and enables the precision focus of therapeutic signals from small molecule or biological actives at the site of repair. TAOSTM has many potential application sites across the body.
Pipeline technology includes RPMax, a thermo-reversible matrix, and IntraStem, a new delivery system for cells; technologies that can meet industry recognised needs to advance cell therapy markets such as transfection, genome editing and induced pluripotent stem cells.
News and press releases
Neupulse raises £918k in a second round of funding
- 20th January 2023 1:05 pm·
SurePulse and partners land £1.4m Innovate UK award
- 2nd November 2022 1:37 pm·
PBD Biotech raises further £2.4m for its breakthrough tuberculosis blood test
- 27th October 2022 11:40 am·
Nottingham trio share award for brain imaging innovation
- 27th October 2022 11:28 am·
Face and voice recognition technology set to transform diagnosis of perinatal depression
- 20th October 2022 4:01 pm·
BlueSkeye AI wins ‘One to Watch’ Award at Medilink Business Awards 2022
- 2nd February 2022 12:22 pm·
Data privacy startup ID Ward raises €1.1 million to launch its decentralised advertising technology
- 2nd February 2022 11:53 am·
NuVision Biotherapies announces the appointment of its new Chief Executive Officer and Chief Operating Officer
- 13th January 2022 11:43 am·
BlueSkeye AI shortlisted as a finalist for the Medilink Midlands Business Awards 2022
- 17th December 2021 12:40 pm·
University spin-out named best medtech start-up
- 29th November 2021 2:47 pm·
Green jobs at Cheesecake Energy
- 1st November 2021 4:07 pm·
Steve Cliffe joins BlueSkeye AI as it scales the development of its technology and customer portfolio
- 26th October 2021 9:36 am·
Cheesecake Energy announces new board appointments
- 5th October 2021 4:05 pm·

@locatebio on Twitter
At Locate Bio, we are bucking the gender trend in STEM, with 80% of our employees female! We will be celebrating International Women and Girls in Science day on the 11th of Feb!
Locate Bio is proud to be part of an incredible industry working hard towards relieving suffering and delivering better outcomes for patients worldwide. https://youtu.be/G_dfV44J8fk via @YouTube
In our 2nd abstract accepted for presentation at Spineweek 2023, we will be sharing data from our recently completed study of interbody fusion in a skeletally mature ovine model. Exciting results from Locate's proprietary #ProgrammedDrugRelease of #BMP2
https://tinyurl.com/2mzvfn67
We are very pleased to have not just 1 but 2 abstracts accepted for presentation at Spineweek 2023! CertOss Conduit showed clear new bone formation at just 6 weeks when implanted intramuscularly, with strong bone growth progressing through to 12 weeks. https://tinyurl.com/mr3dvdb8
5. @LocateBio, John von Benecke, CEO
→ Locate Bio provides surgeons with next-generation orthobiologics so they can relieve suffering and restore quality of life for the 1.7 billion people around the globe who suffer from muscular-skeletal conditions.
@lsintelligence @adaptiximaging @adaptiximaging Looking forward to seeing you present in March!
@MedTechStrat @MedTechStrat we’re looking forward to showcasing Locate Bio’s programmed drug release pipeline in Dublin
The global population is ageing rapidly. Click the infographic below to see the dramatic country-by-country change between 1950 and 2100. This will have profound implications for global healthcare
Global ageing population Visualised with @f_l_o_u_r_i_s_h

Global ageing population
A Flourish data visualisation by John von Benecke
public.flourish.studio